Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,171	1,347	2,086	2,117	1,935	1,544
Revenue Growth (YoY)	-22.29%	-35.42%	-1.45%	9.43%	25.34%	33.45%
Cost of Revenue	922.42	953.06	1,329	1,155	985.31	856.84
Gross Profit	249.07	394.32	757.31	961.76	949.39	686.75
Selling, General & Admin	158.48	182.14	233.8	271.78	239.89	202.1
Research & Development	190.18	205.84	242.7	244.79	252.67	215.73
Operating Expenses	348.65	387.98	476.5	498.23	510.91	417.83
Operating Income	-99.58	6.34	280.81	463.53	438.48	268.92
Interest Expense	-17.95	-21.13	-17.97	-9.68	-3.27	-4.76
Interest & Investment Income	8.32	8.65	8.25	4.51	0.18	0.42
Earnings From Equity Investments	47.31	44.87	36.51	51.1	50.1	37.9
Currency Exchange Gain (Loss)	23.64	23.64	6.88	56.82	-9.59	-11.82
Other Non Operating Income (Expenses)	-37.59	9.68	8.25	8.13	18.45	8.51
EBT Excluding Unusual Items	-75.86	72.04	322.72	574.41	494.34	299.18
Gain (Loss) on Sale of Investments	-15.42	-15.42	10.77	9.59	3.27	4.3
Gain (Loss) on Sale of Assets	0.61	0.61	-	-0.7	-	346.83
Pretax Income	-90.67	57.22	333.49	583.31	497.61	650.3
Income Tax Expense	-22.06	4.19	68.58	117.17	96.56	118.23
Earnings From Continuing Operations	-68.61	53.03	264.91	466.14	401.05	532.06
Minority Interest in Earnings	-	-	-	-0.28	-0.27	-0.19
Net Income	-68.61	53.03	264.91	465.87	400.78	531.87
Net Income to Common	-68.61	53.03	264.91	465.87	400.78	531.87
Net Income Growth	-	-79.98%	-43.14%	16.24%	-24.65%	354.58%
Shares Outstanding (Basic)	45	56	78	78	78	78
Shares Outstanding (Diluted)	45	56	78	79	78	78
Shares Change (YoY)	-42.58%	-27.92%	-0.52%	0.23%	-0.02%	0.16%
EPS (Basic)	-1.53	0.95	3.42	6.01	5.17	6.86
EPS (Diluted)	-1.54	0.94	3.39	5.93	5.12	6.79
EPS Growth	-	-72.27%	-42.83%	15.82%	-24.59%	352.67%
Free Cash Flow	233.08	364.57	-516.27	359.12	-184.18	-53.38
Free Cash Flow Per Share	5.21	6.48	-6.61	4.58	-2.35	-0.68
Dividend Per Share	0.190	0.190	0.800	1.300	1.300	1.500
Dividend Growth	-76.25%	-76.25%	-38.46%	-	-13.33%	87.50%
Gross Margin	21.26%	29.27%	36.30%	45.43%	49.07%	44.49%
Operating Margin	-8.50%	0.47%	13.46%	21.89%	22.66%	17.42%
Profit Margin	-5.86%	3.94%	12.70%	22.00%	20.71%	34.46%
Free Cash Flow Margin	19.90%	27.06%	-24.74%	16.96%	-9.52%	-3.46%
EBITDA	96.54	205.5	473.81	632.58	570.47	400.07
EBITDA Margin	8.24%	15.25%	22.71%	29.88%	29.49%	25.92%
D&A For EBITDA	196.12	199.16	193.01	169.05	131.99	131.15
EBIT	-99.58	6.34	280.81	463.53	438.48	268.92
EBIT Margin	-8.50%	0.47%	13.46%	21.89%	22.66%	17.42%
Effective Tax Rate	-	7.32%	20.56%	20.09%	19.41%	18.18%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.